Vaccines Conferences | Immunology Conferences | World …

Conference Series LLClook forward to welcoming all the participants across the globe to attend19thEuro Global Summit and Expo on Vaccines & Vaccinationgoing to be held duringJune 19-21, 2016 in Paris, France. The conference highlights the theme Accelerating Next Generation Vaccines for Global Health covering all important aspects in Vaccines and therapeutics.

Euro Vaccines 2017conference features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of vaccination and therapeutics. The conference includes explicit keynote talks from distinguished scientists, plenary sessions, Poster competition, Young Researcher sessions, Symposiums, Workshop and Exhibitions.

Track 1:Human Vaccines - Infectious & Non Infectious Diseases

Avaccineis an inactivated form of bacteria or virus that is injected into the body to simulate an actualinfection. Because the injected microorganisms are 'dead,' they don't cause a person to become sick. Instead, vaccines stimulate animmune responseby the body that will fight off that type of illness. It covers infectious disease targets and non-infectious disease targets. To generate vaccine-mediated protection is a complex challenge. Currently available vaccines have largely been developed empirically, with little or no understanding on how they activate theimmune system. Their early protective efficacy is primarily conferred by the induction of antigen-specific antibodies. However, there is more to antibody-mediated protection than the peak of vaccine-induced antibody titers.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 2:Vaccine Research & Development:

Vaccine Developmentis an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedentedEbola diseaseoutbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccines development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 3:Cancer Vaccines:

Immunotherapeuticsis treatment that uses your body's own immune system to help fight cancer. Get information about the different types of immunotherapy and the types of cancer they are used to treat. The main types of immunotherapy now being used to treat cancer include:

Some types ofimmunotherapyare also sometimes called biologic therapy or biotherapy.

In the last few decades immunotherapy has become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and theyll impact how we treat cancer in the future.

Immunotherapy includes treatments that work in different ways. Some boost the bodys immune system in a very general way. Others help train the immune system to attack cancer cells specifically. Immunotherapy works better for some types of cancer than for others. Its used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; InternationalConference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Australia; 12th Euro GlobalSummit on Cancer Therapy, Sept 26-28, 2016, UK; InternationalConference and Exhibition on Pediatric Oncology, Aug 4-6, 2016, Canada; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; World;Vaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 4:HIV Vaccines:

AnAIDSvaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A preventive vaccine would stopHIV infectionoccurring altogether, whereas a therapeutic vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, therapeutic vaccines would also be highly beneficial. The basic idea behind allHIV vaccinesis to encourage the humanimmune systemto fight HIV.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; AnnualConference on Virulent HIV Vaccines, July 28-30, 2016 Thailand; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; HIV Research for Prevention 2016, 17-21 October, Chicago, USA; InternationalAIDS Conference2016, July 17-19, 2016, Durban, South Africa;HIV Trials Network Meeting, MAY 18-20, 2016, Washington D.C., USA;HIV Vaccines(X8), March 2024, 2016, California, USA;HIV Research for Prevention2016 (HIVR4P), October 17- 20, 2016, Chicago, USA

Track 5:Vaccines safety& Efficacy:

Vaccines are the best defense we have against serious, preventable, and sometimes deadlycontagious diseases. Vaccines are some of the safest medical products available, but like any other medical product, there may behealth risk. Accurate information about the value of vaccines as well as their possibleside-effectshelps people to make informed decisions about vaccination. The safety of vaccines is carefully monitored, starting early in the product development and continuing for as long as the vaccine is being used. Find out about what is done before and after vaccines are approved for use and what is known about the benefits and safety of specific vaccines. There is a lot of false information about vaccines safety on the Internet. This can be confusing. Discover the answers to common questions and concerns about vaccines.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Track 6:Vaccination for Pregnant Women:

Vaccines can help keep you and your growing family healthy. If you are pregnant or planning apregnancy, the specific vaccinations you need are determined by factors such as your age, lifestyle, medical conditions you may have, such as asthma or diabetes, type and locations of travel, and previous vaccinations. Benefits of vaccinating pregnant women usually outweigh potential risks when the likelihood of disease exposure is high, when infection would pose a risk to the mother or fetus, and when the vaccine is unlikely to cause harm. All women who will be pregnant (any trimester) during the flu season should be offered this vaccine. Talk to your doctor to see if this applies to you.Tetanus/Diphtheria/Pertussis(Tdap): Tdap is recommended during pregnancy, preferably between 27 and 36 weeks' gestation, to protect baby from whooping cough.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France;Pregnancy Summit& Child Health, Aug 29-31, 2016, Brazil; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 7:Childhood Vaccines:

Vaccinationgiven to children is called childrenImmunization. It is currently recommended that all children receive vaccination against the infectious diseases unless the child has special circumstances, such as a compromised immune system orneurological disorders. In our mobile society, over a million people each day people travel to and from other countries, where many vaccine-preventable diseases remain relatively common. Without vaccines, epidemics of many preventable diseases could return, resulting in increased - and unnecessary - illness, disability, and death among children.

We have record or near record low levels of vaccine-preventable childhood diseases in the United States, but that does not mean these have disappeared. Many of the viruses and bacteria are still circulating in this country or are only a plane ride away. Thats why its important that children, especially infants and young children receive recommended immunizations on time.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France;Children Vaccines Conference, Oct 10-12, 2016 Rome, Italy; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, Chicago, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA

Track 8:Vaccine Adjuvants & Delivery Technologies:

Vaccine adjuvants - is an ingredient of a vaccine that helps create a stronger immune response in the patients body. In other words, adjuvants help vaccines work better. Some vaccines made from weakened or dead germs contain naturally occurring adjuvants and help the body produce a strong protectiveimmune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. These vaccines often must be made with adjuvants to ensure the body produces an immune response strong enough to protect the patient from the germ he or she is being vaccinated against. Aluminum gels or aluminum salts are vaccines ingredients that have been used in vaccines since the 1930s. Small amounts of aluminum are added to help the body build strongerimmunityagainst the germ in the vaccine. Aluminum is one of the most common metals found in nature and is present in air, food, and water. The amount of aluminum present in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA).

Drug deliverysystems are engineered technologies for the targeted delivery and/or controlled release of therapeutic agents. Drugs have long been used to improve health and extend lives. The practice of drug delivery has changed dramatically in the last few decades and even greater changes are anticipated in the near future. Biomedical engineers have not only contributed substantially to our understanding of the physiological barriers to efficient drug deliverysuch as transport in the circulatory system and drug movement through cells and tissuesthey have contributed to the development of a number of new modes of drug delivery that have entered clinical practice. Role of vaccine delivery technologies includes rational development of vaccines, achievingimmunizationgoals, supporting best clinical practice.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 8th InternationalConference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 7-9, 2016, Spain; 9th WorldDrug Delivery Summit, June 30-July 2, 2016, USA; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE;Drug Delivery CongressEurope, Germany; 13th Annual InternationalNanomedicine and Drug Delivery Symposium, USA;Vaccines for Children & Vaccine Preventable Disease ConferenceSouth Iselin, NJ; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA

Track 9:Immunization for Older Adults:

Vaccines are an important part of routine preventive care for older adults, but most adults dont get their vaccines as recommended. Omittingvaccinationleaves adults needlessly vulnerable to severe illnesses, long-term suffering and death from preventable infections. Vaccines are recommended for adults of all ages, they are particularly important for older persons who are at great risk of serious debilitating consequences and death frominfectious diseases. Vaccination is particularly important for individuals living in nursing homes or assisted living facilities, as disease can spread easily among people in close proximity.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France;Geriatric Medicine Conference, Nov 17-19, 2016, USA; 3rd InternationalConference on Geriatrics & Gerontology, Aug 15-17, 2016, UK; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 10:Vaccines against Viral and Bacterial Diseases:

Most vaccines againstviral infectionare effective at preventing disease. However, they are not 100% effective for a number of reasons, reactions can occur after vaccinations.

It is difficult for many of us today to appreciate the dangers of childhood viral infections.

Most of the vaccines in use againstvirusesare very effective at preventingdisease. However, for a variety of reasons, they can fail:

The different vaccine combinations at each time point do not interfere with one another and there is no increased risk of serious side-effects when they are given at the same time.

Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Antibodies are built against that particular bacteria, and prevents bacterial infection later.

Most vaccines against bacterial infections are effective at preventing disease, reactions can occur after vaccinations. Vaccines are available againsttuberculosis,diphtheria,tetanus,pertussis, Haemophilus influenzae type B,cholera, typhoid, and Streptococcus pneumoniae.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia;Vaccine Summit, UK; BIT's 6th AnnualWorld Congress of Vaccine, China; 9thVaccines & ISV Congress, South Korea; WorldVaccines Congress, USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 2ndAntivirals CongressMassachusetts, United States;Vaccinology conferenceSydney Australia;Vaccines R&D conference-2015 A New Era in Vaccine Discovery Baltimore, USA; MoldovaVaccine Summit, UK;Immunotherapy and Vaccine SummitBoston, USA

Track 11:DNA Vaccines:

DNA vaccinationis a technique for protecting an animal against disease by injecting it with genetically engineered DNA so cells directly produce an antigen, resulting in a protective immunological response.

Vaccinationconsists of stimulating the immune system with an infectious agent, or components of an infectious agent, modified in such a manner that no harm or disease is caused, but ensuring that when the host is confronted with that infectious agent, the immune system can adequately neutralize it before it causes any ill effect. For over a hundred years vaccination has been effected by one of two approaches: either introducing specific antigens against which the immune system reacts directly; or introducing live attenuated infectious agents that replicate within the host without causing disease synthesize the antigens that subsequently prime theimmune system.

The field of DNA vaccination is developing rapidly. Vaccines currently being developed use not only DNA, but also include adjuncts that assist DNA to enter cells, target it towards specific cells, or that may act as adjuvants in stimulating or directing theimmune response. Ultimately, the distinction between a sophisticated DNA vaccine and a simple viral vector may not be clear. Many aspects of the immune response generated by DNA vaccines are not understood. However, this has not impeded significant progress towards the use of this type of vaccine in humans, and clinical trials have begun.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Track 12:HPV Vaccines:

Human Papillomavirus (HPV)vaccine is an inactivated (not live) vaccine which protects against four major types of HPV.

These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Protection from HPV vaccine is expected to be long-lasting. But vaccinated women still need cervical cancer screening because the vaccine does not protect against all HPV types that cause cervical cancer.

RoutineHPV Vaccination

It is important for girls to get HPV vaccine before their first sexual contact -- because they have not been exposed to HPV. For these girls, the vaccine can prevent almost 100% of disease caused by the four types of HPV targeted by the vaccine. However, if a girl or woman is already infected with a type of HPV, the vaccine will not prevent disease from that type. The vaccine is also recommended for girls and women 13 through 26 years of age who did not receive it when they were younger.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; InternationalConference on Human Papillomavirus, May 2-3, 2016, USA; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA; Annual PennsylvaniaImmunization Conference, June 16, 2016, PA,USA

Track 13:Tuberculosis Vaccines:

BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculousmeningitisand miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection withMycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccines potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; 13thAnnualConference on H1N1 & Influenza Vaccines, December 01-02, 2016, USA; 14th GlobalVaccines & Vaccination Summit and Expo, December 05-06, 2016, UAE; 11thGlobalSummit and Expo on Vaccines & Vaccination, Sept 12-14, 2016, USA; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; The 2016TB Summit: 21 23 June 2016, London, UK;EMBO conference Tuberculosis2016, September 19-23, 2016, Paris, France; 20th AnnualTB Conference, February 24-27, 2016, Colorado, USA; ICTT 2016 : 18th InternationalConference on Tuberculosis Therapy, February 25 - 26, 2016, London, United Kingdom; 47th Union WorldConference on Lung Health, 25-29 October 2016, Liverpool, UK; Joint 20thConference of The Union North America Region and the National TB Controllers Association, 24-27 February 2016, Colorado, USA

Track 14:Mucosal vaccines:

Mostinfectious agentsenter the body at mucosal surfaces and therefore mucosal immune responses function as a first line of defence. Protective mucosal immune responses are most effectively induced by mucosal immunization through oral, nasal, rectal or vaginal routes, but the vast majority of vaccines in use today are administered by injection. Immunisation involves the delivery of antigens to the mucosalimmune system(dispersed or organised into units such as Peyers patches in the intestine or the nasal-associated lymphoidtissuein the oropharangeal cavity). The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Track 15:Vaccines for Vector-borne Diseases:

Vaccines that target blood-feeding disease vectors, such as mosquitoes and ticks, have the potential to protect against the many diseases caused by vector-borne pathogens.Vector-borne diseasesare among the most complex of all infectious diseases to prevent and control. Vector- borne diseases, most of which are transmitted in and around the home, are best controlled by a combination of vector control (use of public health insecticides on bednets, or by spraying), medicines and vaccines.

Historically, successful vector-borne disease prevention resulted from management or elimination of vector populations.Malariawas driven out of the USA and most of Europe in this way. Where vector control has been consistently applied in the past, the results have been dramatic, especially with early efforts to control malaria by spraying the inside surfaces of houses with insecticides. Indoor Residual Spraying (IRS) and long-lasting insecticide treated bednets have been very effective over the last 10 years and are widely regarded as one of the main contributors to the more than 1 million lives saved.

In contrast to expenditure and effort on medicine, diagnostic andvaccine development, relatively little attention was given to vector control in the past. The foresighted establishment of IVCC in 2005, with a grant from the Bill and Melinda Gates Foundation began the process of bringing Vector Control into the mainstream strategy for future eradication of malaria and other vector-borne diseases.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Vaccines Conferences, June 19-21, 2017, Paris, France; InternationalConference on Cancer Immunology and Immunotherapy, July 28-30, 2016, Australia; 12th Euro GlobalSummit on Cancer Therapy, Sept 26-28, 2016, UK; InternationalConference and Exhibition on Pediatric Oncology, Aug 4-6, 2016, Canada; 12th Asia Pacific GlobalSummit and Expo on Vaccines & Vaccination, November 24-25, Australia; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; NationalAdult & Influenza Immunization SummitNAIIS, May 1012, 2016; 10th ISVAnnual Vaccine Congress, Oct. 2-4, 2016, Boston, USA; WorldVaccines Congress, 10-12 April, Washington D.C., USA; 6thImmunotherapeutics Immunomonitoring ConferenceCalifornia, USA; 10thVaccine Congress, 4-7 September 2016, Amsterdam, The Netherlands, USA; FDAVaccines & Related Biological Products Advisory Committee Meeting(VRBPAC) May 11, 2016, MD, USA; WyomingImmunization Conference, May 1112, 2016, WY, USA; 14thAnnual Vaccines & Therapeutics, May 1719, 2016, Washington D.C., USA; 2016 NationalConference on Immunization Coalitions & Partnerships, May 2527, 2016, USA

Track 16:Human Preventive& Therapeutic Vaccines:

Apreventative vaccineis administered to a person who is free of the targeted infection. By introducing a part of the virus or an inactive virus (which acts like a decoy) into the body, the immune system reacts by producing antibodies. Preventive vaccines are widely used to prevent diseases likepolio,chicken pox,measles, mumps, rubella,influenza(flu), and hepatitis A and B.

In addition to preventive vaccines, there are also therapeutic vaccines. These are vaccines that are designed to treat people who already have a disease. Some scientists prefer to refer to therapeutic vaccines as therapeutic immunogens.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Track 17:Plant-based vaccines:

Plant-basedvaccinesare recombinant protein subunit vaccines. Ideally, the choice of plant species used to produce the selected antigen should allow for oraldrug deliveryin the form of an edible vaccine. To date, the most advanced human vaccine projects have successfully completed phase I clinical trials, andanimal vaccineprojects have given promising data in early phase trials targeting specific animal species.

The plant-based vaccine production method works by isolating a specific antigen protein, one that triggers a humanimmune responsefrom the targeted virus. A gene from the protein is transferred to bacteria, which are then used to infect plant cells. The plants then start producing the exact protein that will be used for vaccinations. The flexibility of the plant expressed vaccine system, combined with its low cost and ability to massively scale may provide vaccine protection not only to citizens of the United States, but to many parts of the world that cannot currently afford vaccines. Other uses of plant expressed vaccines including the successful creation of edible bananas that protect against the Norwalk virus.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Track 18: Veterinary vaccines:

Veterinary vaccinesare to improve the health and welfare of companion animals, increase production of livestockin a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. Several vaccine types can de distinguished among the second-generation veterinary vaccines, depending whether they are live or inactivated, according to the strain of rabies virus used and the characteristics of the cell substrate chosen for viral replication. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parenterally or orally.Oral rabies vaccinesare widely used in foxes in Europe and in racoons in the USA.

Vaccines Conferences|Immunology Conferences|World Vaccines Congress

Read the original post:
Vaccines Conferences | Immunology Conferences | World ...

Sir Gustav Nossal Professor of Immunology to honour giant of Australian science - Walter and Eliza Hall Institute of Medical Research - December 9th, 2024 [December 9th, 2024]
Research Assistant in Immunology - Surrey, United Kingdom job with UNIVERSITY OF SURREY | 384335 - Times Higher Education - November 28th, 2024 [November 28th, 2024]
Reflecting on Pioneering organoids and 3D cell cultures for animal and human health - British Society for Immunology | - November 28th, 2024 [November 28th, 2024]
Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET - Business Wire - November 20th, 2024 [November 20th, 2024]
TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development - Business Wire - November 20th, 2024 [November 20th, 2024]
Discovering Solutions for Long COVID: A T-Cell Immunology Breakthrough - Infection Control Today - November 20th, 2024 [November 20th, 2024]
Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501 - The Bakersfield Californian - November 20th, 2024 [November 20th, 2024]
Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of... - November 20th, 2024 [November 20th, 2024]
What it's like in allergy and immunology: Shadowing Dr. Fraser - American Medical Association - November 12th, 2024 [November 12th, 2024]
Dr. Naba Sharif Elected President of the New Jersey Allergy Asthma and Immunology Society - Newswire - November 12th, 2024 [November 12th, 2024]
Department of Microbiology and Immunology Named a National Milestones Program - Stony Brook News - October 26th, 2024 [October 26th, 2024]
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - businesswire.com - October 26th, 2024 [October 26th, 2024]
Remembering immunology educator, researcher Tom McDonald, PhD - University of Nebraska Medical Center - October 13th, 2024 [October 13th, 2024]
Systems immunology approaches to study T cells in health and disease - Nature.com - October 13th, 2024 [October 13th, 2024]
Leading the charge to discover answers in immunology - The University of Arizona - October 2nd, 2024 [October 2nd, 2024]
New mouse models offer valuable window into COVID-19 infection - La Jolla Institute for Immunology - October 2nd, 2024 [October 2nd, 2024]
Wide-Moat AbbVie Poised for Growth, Driven by Innovation in Immunology Beyond Humira - Morningstar - October 2nd, 2024 [October 2nd, 2024]
Lilly's immunology unit scores another FDA nod with eczema treatment Ebglyss - FiercePharma - September 23rd, 2024 [September 23rd, 2024]
Huang Named Head Of Pathology And Immunology - Mirage News - September 15th, 2024 [September 15th, 2024]
Huang named head of pathology & immunology - Washington University School of Medicine in St. Louis - September 15th, 2024 [September 15th, 2024]
Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit - Yahoo Finance - September 15th, 2024 [September 15th, 2024]
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - StockTitan - September 15th, 2024 [September 15th, 2024]
UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy - UCLA Newsroom - September 2nd, 2024 [September 2nd, 2024]
Boosting vaccines for the elderly with 'hyperactivators' - Boston Children's Answers - Boston Children's Discoveries - June 27th, 2024 [June 27th, 2024]
Immunologists Want You to Know These Dust Mite Allergy Facts - Yahoo Lifestyle UK - June 27th, 2024 [June 27th, 2024]
How Ragon Institute's new building aids its mission Harvard Gazette - Harvard Gazette - June 27th, 2024 [June 27th, 2024]
Insights into CRS and NPs: Visual and Bibliometric Analysis - Physician's Weekly - June 27th, 2024 [June 27th, 2024]
Biogen joins immunology wave with $1.15 billion acquisition of HI-Bio - STAT - May 24th, 2024 [May 24th, 2024]
Biogen Buys Desired Growth In Immunology With $1.15bn Hi-Bio Deal - Scrip - May 24th, 2024 [May 24th, 2024]
Biogen Boosts Immunology Portfolio with $1.8 Billion Acquisition of HI-Bio - BioPharm International - May 24th, 2024 [May 24th, 2024]
Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395 - Yahoo Finance - May 24th, 2024 [May 24th, 2024]
Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition - PMLiVE - May 24th, 2024 [May 24th, 2024]
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress - Business Wire - May 24th, 2024 [May 24th, 2024]
Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B - MM+M Online - May 24th, 2024 [May 24th, 2024]
COVID-19 Re-Vaccinations Elicit Neutralizing Antibodies Against Future Variants - Technology Networks - May 24th, 2024 [May 24th, 2024]
HIV Vaccine Candidate Induces Broadly Neutralizing Antibodies in Humans - Technology Networks - May 24th, 2024 [May 24th, 2024]
Pasteur Fiocruz Center on Immunology and Immunotherapy is inaugurated in Cear - Fiocruz - May 24th, 2024 [May 24th, 2024]
Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal - Marketscreener.com - May 24th, 2024 [May 24th, 2024]
Fellow Focus in Four: Marat Kribis, MD, Rheumatology, Allergy and Immunology - Yale School of Medicine - April 15th, 2024 [April 15th, 2024]
Long COVID Can Now Be Detected in the Blood - Technology Networks - April 15th, 2024 [April 15th, 2024]
Rimjhim Agarwal selected as Major Symposium speaker at the American Association of Immunologists ... - La Jolla Institute for Immunology - March 29th, 2024 [March 29th, 2024]
Seeking new horizons: Where innovators find opportunities in a fast-changing immunology landscape - IQVIA - March 29th, 2024 [March 29th, 2024]
Researchers identify new way to inhibit immune cells that drive allergic asthma - EurekAlert - March 29th, 2024 [March 29th, 2024]
Innovation in Oncology and Cancer Immunology Research - Boehringer Ingelheim - March 29th, 2024 [March 29th, 2024]
Measles outbreaks show the risk of under-vaccination | News | Harvard T.H. Chan School of Public Health - HSPH News - March 29th, 2024 [March 29th, 2024]
Immunology-oncology ELISA Kits Market to Witness a Healthy Growth by 2030 - WhaTech - March 29th, 2024 [March 29th, 2024]
Spring Allergy Season Is Getting Worse. Here's What to Know. - The New York Times - March 29th, 2024 [March 29th, 2024]
Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments - STAT - March 29th, 2024 [March 29th, 2024]
Researchers identify viable vaccine targets for hepatitis C infections - News-Medical.Net - March 29th, 2024 [March 29th, 2024]
Three research projects awarded funding from the Immunology Institute Pilot Project program - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
Deal Watch: AbbVie Adds To Immunology Pipeline Through Deal With OSE - Scrip - February 29th, 2024 [February 29th, 2024]
AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology ... - PR Newswire - February 29th, 2024 [February 29th, 2024]
Integrating single-cell multi-omics and prior biological knowledge for a functional characterization of the immune system - Nature.com - February 29th, 2024 [February 29th, 2024]
Renowned immunologist and four-decade UAB researcher Max Cooper, M.D., will deliver this year's Marx Lecture - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
Inactivation of TGF- signaling in CAR-T cells | Cellular & Molecular Immunology - Nature.com - February 29th, 2024 [February 29th, 2024]
Babies use their immune system differently but efficiently | Cornell Chronicle - Cornell Chronicle - February 29th, 2024 [February 29th, 2024]
Antibody reduces allergic reactions to multiple foods in NIH clinical trial - National Institutes of Health (NIH) (.gov) - February 29th, 2024 [February 29th, 2024]
Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its ... - GlobeNewswire - February 21st, 2024 [February 21st, 2024]
Theratechnologies announces publication in Frontiers in Immunology on TH1902 - TipRanks.com - TipRanks - February 21st, 2024 [February 21st, 2024]
Smoking has long-term effects on the immune system - Institut Pasteur - February 21st, 2024 [February 21st, 2024]
Spring Allergies Attack More Than Just Your Nose - ACAAI Public Website - American College of Allergy Asthma and Immunology - February 21st, 2024 [February 21st, 2024]
Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel ... - GlobeNewswire - February 21st, 2024 [February 21st, 2024]
Shikhar Mehrotra named co-leader of Cancer Biology and Immunology research program at MUSC Hollings - The Cancer Letter - January 27th, 2024 [January 27th, 2024]
Gut Microbiome Benefits of Breast Milk Revealed in Mouse Study - Technology Networks - January 27th, 2024 [January 27th, 2024]
Research on Immunological Diseases Launches with Hungarian Participation - Hungary Today - January 27th, 2024 [January 27th, 2024]
UCLA to turn former shopping mall into centers for research on immunology and quantum science - The Associated Press - January 8th, 2024 [January 8th, 2024]
TRexBio Announces a First Option Was Exercised by Partner under Immunology Discovery Collaboration - Business Wire - January 8th, 2024 [January 8th, 2024]
UCLA to turn former Westside Pavilion into centers for research on immunology and quantum science - KABC-TV - January 8th, 2024 [January 8th, 2024]
HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases - PR Newswire - January 8th, 2024 [January 8th, 2024]
Beyond Cytotoxicity: The Importance of T Cell Memory - The Scientist - January 8th, 2024 [January 8th, 2024]
IKAROS: Unlocking the secrets of the immune system's key player - News-Medical.Net - January 8th, 2024 [January 8th, 2024]
UCLA to turn former shopping mall into centers for research on immunology and quantum science - The Caledonian-Record - January 8th, 2024 [January 8th, 2024]
Revolutionizing Vaccine Research: The Power of a New Algorithm - SciTechDaily - December 31st, 2023 [December 31st, 2023]
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people ... - Nature.com - December 22nd, 2023 [December 22nd, 2023]
Two new practice parameters offer recommendations for treating anaphylaxis and atopic dermatitis - News-Medical.Net - December 22nd, 2023 [December 22nd, 2023]
Physician and Patient (Un)Wellness in Allergy and Immunology During COVID-19 and Beyond: Lessons for the Future - Physician's Weekly - December 22nd, 2023 [December 22nd, 2023]
Researchers Identify Why Some Cancers Do Not Respond to Immunotherapy - NYU Langone Health - December 22nd, 2023 [December 22nd, 2023]
MU's Haval Shirwan recognized for achievements in immunology - Columbia Daily Tribune - December 22nd, 2023 [December 22nd, 2023]
Parker Institute for Cancer Immunotherapy (PICI) Welcomes Weill Cornell Medicine to Cancer Research Consortium - Weill Cornell Medicine Newsroom - December 14th, 2023 [December 14th, 2023]
Annals of Allergy, Asthma and Immunology Examines Effects of Climate Change on Allergic Conditions - Newswise - December 14th, 2023 [December 14th, 2023]